Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
about
Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Priority review vouchers: an i ...... cted-disease drug development.
@en
Priority review vouchers: an i ...... cted-disease drug development.
@nl
type
label
Priority review vouchers: an i ...... cted-disease drug development.
@en
Priority review vouchers: an i ...... cted-disease drug development.
@nl
prefLabel
Priority review vouchers: an i ...... cted-disease drug development.
@en
Priority review vouchers: an i ...... cted-disease drug development.
@nl
P2860
P356
P1476
Priority review vouchers: an i ...... ected-disease drug development
@en
P2093
A S Kesselheim
P2860
P304
P356
10.1038/CLPT.2009.50
P407
P577
2009-06-01T00:00:00Z